Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Pasireotide Market by Type (0.3mg/ml, 0.6mg/ml, 0.9mg/ml), By Application (Hospital, Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Pasireotide Market by Type (0.3mg/ml, 0.6mg/ml, 0.9mg/ml), By Application (Hospital, Pharmacy) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 325634 4200 Pharma & Healthcare 377 176 Pages 4.9 (49)
                                          

Market Overview:


The global pasireotide market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of pituitary tumors, increasing demand for better treatment options, and growing awareness about pasireotide. The global pasireotide market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 0.3mg/ml, 0.6mg/ml, and 0.9mg/ml segments. On the basis of application, the market is segmented into hospital and pharmacy segments.


Global Pasireotide Industry Outlook


Product Definition:


Pasireotide is a synthetic peptide analogue of somatostatin-14. It is used to treat Cushing's disease and acromegaly.


0.3mg/ml:


0.3mg/ml is a concentration used for the treatment of hypogonadism, also known as testosterone replacement therapy (TRT). It is also used in cases where the patient has low levels of testosterone due to medical conditions such as Leukemia, Cushing syndrome or side effects from cancer treatments. TRT 0.3mg/ml suspension is available in Pasireotide injection and vials containing 10 ml and 30 ml respectively.


0.6mg/ml:


Pasireotide is a nonapeptide, which is a type of protein hormone. It works by increasing the levels of serotonin and melatonin in the body, which helps to treat depression as well as insomnia. The drug was approved by FDA under class III medical products because it has no significant risk related to the use during pregnancy.


Application Insights:


The global market is segmented by application into hospital, pharmacy and others. The hospital segment dominated the market in 2017 owing to growing awareness about cancer treatment and increasing government initiatives for early diagnosis. Pasireotide is used as an alternative therapy for acromegaly and other pituitary disorders due to its ability to reduce prolactin levels.


Pharmacy was the fastest-growing application of pasireotide with a CAGR of XX% from 2018 to 2030 owing to high unmet medical needs associated with these disorders coupled with rising adoption of advanced therapies that are less expensive than surgery or medication. Moreover, increasing number of clinical trials supported by governments across various countries will further boost product demand in this segment over the forecast period.


Regional Analysis:


North America dominated the global pasireotide market in 2017. The presence of a large number of manufacturers and suppliers coupled with high healthcare expenditure, favorable reimbursement policies for innovations in treatment methods and increasing prevalence of kidney diseases are some factors responsible for its largest share. In addition, growing R&D activities by various organizations to improve the quality standards is expected to fuel the product demand over the forecast period.


Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels, improving economic conditions and an increase in healthcare spending especially by governments as well as private sectors within countries such as China & India.


Growth Factors:


  • Increasing prevalence of Cushing's syndrome: The global prevalence of Cushing's syndrome is estimated to be around 20 cases per million population. This number is expected to grow owing to the increasing incidence of obesity and diabetes mellitus. Pasireotide is an effective treatment for Cushing's syndrome and hence, the market for this drug will grow in future.
  • Launch of new products: Novartis, the manufacturer of pasireotide, has plans to launch a new product called Signifor LAR in 2017. This product will be available as a monthly injection and will have a longer duration of action as compared to the currently available formulation (Signifor). The launch of this product will boost the growth prospects for pasireotide market.
  • Growing awareness about pituitary tumors: There is growing awareness among people about pituitary tumors and their associated symptoms such as excessive sweating, headache, etc.). As a result, there is an increase in demand for drugs such as pasireotide that can effectively treat these tumors.

Scope Of The Report

Report Attributes

Report Details

Report Title

Pasireotide Market Research Report

By Type

0.3mg/ml, 0.6mg/ml, 0.9mg/ml

By Application

Hospital, Pharmacy

By Companies

Novartis, Novartis

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

176

Number of Tables & Figures

124

Customization Available

Yes, the report can be customized as per your need.


Global Pasireotide Market Report Segments:

The global Pasireotide market is segmented on the basis of:

Types

0.3mg/ml, 0.6mg/ml, 0.9mg/ml

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Pharmacy

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Novartis
  2. Novartis

Global Pasireotide Market Overview


Highlights of The Pasireotide Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 0.3mg/ml
    2. 0.6mg/ml
    3. 0.9mg/ml
  1. By Application:

    1. Hospital
    2. Pharmacy
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Pasireotide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Pasireotide Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Pasireotide is a peptide hormone that regulates energy metabolism in the body. It helps to control blood sugar levels and promotes weight loss.

Some of the key players operating in the pasireotide market are Novartis, Novartis.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pasireotide Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Pasireotide Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Pasireotide Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Pasireotide Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Pasireotide Market Size & Forecast, 2020-2028       4.5.1 Pasireotide Market Size and Y-o-Y Growth       4.5.2 Pasireotide Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 0.3mg/ml
      5.2.2 0.6mg/ml
      5.2.3 0.9mg/ml
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Pharmacy
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Pasireotide Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Pasireotide Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 0.3mg/ml
      9.6.2 0.6mg/ml
      9.6.3 0.9mg/ml
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Pharmacy
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 0.3mg/ml
      10.6.2 0.6mg/ml
      10.6.3 0.9mg/ml
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Pharmacy
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 0.3mg/ml
      11.6.2 0.6mg/ml
      11.6.3 0.9mg/ml
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Pharmacy
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 0.3mg/ml
      12.6.2 0.6mg/ml
      12.6.3 0.9mg/ml
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Pharmacy
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 0.3mg/ml
      13.6.2 0.6mg/ml
      13.6.3 0.9mg/ml
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Pharmacy
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Pasireotide Market: Competitive Dashboard
   14.2 Global Pasireotide Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Novartis
      14.3.2 Novartis

Our Trusted Clients

Contact Us